Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits

Cell
Kole T RoybalWendell A Lim

Abstract

T cells can be re-directed to kill cancer cells using chimeric antigen receptors (CARs) or T cell receptors (TCRs). This approach, however, is constrained by the rarity of tumor-specific single antigens. Targeting antigens also found on bystander tissues can cause life-threatening adverse effects. A powerful way to enhance ON-target activity of therapeutic T cells is to engineer them to require combinatorial antigens. Here, we engineer a combinatorially activated T cell circuit in which a synthetic Notch receptor for one antigen induces the expression of a CAR for a second antigen. These dual-receptor AND-gate T cells are only armed and activated in the presence of dual antigen tumor cells. These T cells show precise therapeutic discrimination in vivo-sparing single antigen "bystander" tumors while efficiently clearing combinatorial antigen "disease" tumors. This type of precision dual-receptor circuit opens the door to immune recognition of a wider range of tumors. VIDEO ABSTRACT.

References

May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Cor H J LamersEgbert Oosterwijk
Sep 17, 2008·Proceedings of the National Academy of Sciences of the United States of America·Brian A RabinovichPatrick Hwu
Mar 31, 2009·Current Opinion in Immunology·Michel SadelainIsabelle Rivière
Oct 28, 2009·Nature Reviews. Immunology·Carl H JuneJames L Riley
Feb 25, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Richard A MorganSteven A Rosenberg
May 21, 2010·Nature Reviews. Molecular Cell Biology·Wendell A Lim
Aug 13, 2011·The New England Journal of Medicine·David L PorterCarl H June
Feb 5, 2013·Journal of Immunotherapy·Richard A MorganSteven A Rosenberg
Mar 27, 2013·The New England Journal of Medicine·Stephan A GruppCarl H June
Nov 28, 2013·Annual Review of Medicine·David M BarrettCarl H June
Dec 18, 2013·Immunological Reviews·Gianpietro DottiMalcolm K Brenner
Dec 18, 2013·Science Translational Medicine·Victor D FedorovMichel Sadelain
Dec 24, 2013·Current Opinion in Pediatrics·David M BarrettStephan A Grupp
Jan 18, 2014·Nature Reviews. Molecular Cell Biology·Florian LienertPamela A Silver
Nov 5, 2014·Nature Methods·Peter C FridyMichael P Rout
Jun 9, 2015·Developmental Cell·Wendy R GordonStephen C Blacklow

❮ Previous
Next ❯

Citations

Feb 13, 2016·Cell·Darrell J Irvine
Mar 5, 2016·Nature Reviews. Drug Discovery·Alexandra Flemming
Mar 15, 2016·Trends in Molecular Medicine·Maria Themeli, Michel Sadelain
Jun 10, 2016·ACS Central Science·Gong ZhangPeng R Chen
Jun 10, 2016·ACS Central Science·Maxwell CoyleZev Gartner
May 6, 2016·Chemphyschem : a European Journal of Chemical Physics and Physical Chemistry·Nataliia GuzEvgeny Katz
Jun 9, 2016·Advanced Drug Delivery Reviews·Kelly A Schwarz, Joshua N Leonard
Jun 6, 2016·International Journal of Hematology·Marco L Davila, Michel Sadelain
Jun 18, 2016·Cell·Jun Wu, Juan Carlos Izpisua Belmonte
Jun 25, 2016·Wiley Interdisciplinary Reviews. Systems Biology and Medicine·Lina Schukur, Martin Fussenegger
Jul 4, 2016·Current Opinion in Immunology·Michel Sadelain
Jul 8, 2016·Proceedings of the National Academy of Sciences of the United States of America·Mathieu MorelRoy H Bar-Ziv
Jul 13, 2016·Nucleic Acids Research·Sarah GuiziouJerome Bonnet
Jul 17, 2016·Current Opinion in Structural Biology·Russell M GordleyWendell A Lim
Jul 20, 2016·Expert Opinion on Biological Therapy·Yi Lin, Hideho Okada
Aug 1, 2016·Current Hematologic Malignancy Reports·Marco Ruella, Carl H June
Jul 13, 2016·Developmental Dynamics : an Official Publication of the American Association of Anatomists·Idse Heemskerk, Aryeh Warmflash
Oct 13, 2016·Journal of Translational Medicine·José Eduardo VargasMartin H Bonamino
Oct 18, 2016·Cytotherapy·Allison B PowellConrad Russell Y Cruz
Dec 7, 2016·Nature Medicine·Hannah StowerBrett Benedetti
Dec 16, 2016·British Journal of Haematology·Robert J OrlowskiNoelle V Frey
Dec 13, 2016·Nature Chemical Biology·Kelly A SchwarzJoshua N Leonard
Dec 22, 2016·Immunotherapy·Shunichiro KuramitsuAtsushi Natsume
Dec 28, 2016·Cell Research·Rong-Fu Wang, Helen Y Wang
Jan 17, 2017·Nature Chemical Biology·Marius MüllerMartin Fussenegger
Jan 29, 2017·Trends in Molecular Medicine·Daniel J Woodsworth, Robert A Holt
Mar 28, 2017·Nature Biotechnology·Benjamin H WeinbergWilson W Wong
Mar 23, 2017·Pharmacology & Therapeutics·Jason Lohmueller, Olivera J Finn
Dec 23, 2016·Immunology and Cell Biology·Carmen S M YongMichael H Kershaw
Dec 13, 2016·Angewandte Chemie·Simon AusländerMartin Fussenegger
May 2, 2017·Journal of the American Chemical Society·Ryosuke UekiShinsuke Sando
Jan 20, 2017·Nature Chemical Biology·Matthew BrennerWilson W Wong
Jun 7, 2017·Expert Opinion on Biological Therapy·Robyn A A Oldham, Jeffrey A Medin
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shivani Srivastava, Stanley R Riddell
Dec 19, 2017·Cancer Immunology, Immunotherapy : CII·Else Marit InderbergSébastien Wälchli
Dec 16, 2017·Nucleic Acids Research·Remus S WongChristina D Smolke
May 8, 2018·Nature Biotechnology·Cormac Sheridan
Nov 18, 2017·Oncoimmunology·Carole FournierLionel Apetoh
Aug 11, 2017·Physiological Reviews·Chris Siebel, Urban Lendahl
Nov 14, 2017·Nature Chemical Biology·Ryosuke KojimaMartin Fussenegger
Dec 14, 2017·Frontiers in Immunology·Casey K Hua, Margaret E Ackerman

❮ Previous
Next ❯

Related Concepts

Related Feeds

BioHub - Researcher Network

The Chan-Zuckerberg Biohub aims to support the fundamental research and develop the technologies that will enable physicians to cure, prevent, or manage all diseases in our childrens' lifetimes. The CZ Biohub brings together researchers from UC Berkeley, Stanford, and UCSF. Find the latest research from the CZ Biohub researcher network here.

Cell eTOC

Cell is a scientific journal publishing research across a broad range of disciplines within the life sciences field. Discover the latest research from Cell here.